Form 4 Tracker
IONIS PHARMACEUTICALS INC
IONS

63 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 1, 2026Jul 1 9:29 PMKLEIN JOSEPH III
Proposed Sale
11,518$79.04$910.4K

View →

Jun 26, 2026Jun 30 9:48 PMJoseph BaroldiEVP, Chief Business Officer
Sale
5,635$80.16$451.7K4,669(I)

View →

Jun 26, 2026Jun 30 9:48 PMPatrick R. O'NeilEVP CLO & General Counsel
Sale
3,069$80.00$245.5K61,470(D)

View →

Jun 26, 2026Jun 30 9:48 PMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Sale
26,000$81.05$2.1M77,114(D)

View →

Jun 26, 2026Jun 26 11:09 PMBrett P MoniaDirector, Chief Executive Officer
Sale
50,000$80.59$4.0M245,571(D)

View →

Jun 25, 2026Jun 26 11:09 PMBrett P MoniaDirector, Chief Executive Officer
Sale
21,072$78.49$1.7M245,571(D)

View →

Jun 24, 2026Jun 26 11:09 PMBrett P MoniaDirector, Chief Executive Officer
Sale
14,565$78.41$1.1M245,571(D)

View →

Jun 25, 2026Jun 26 11:09 PMEric SwayzeEVP Research
Sale
10,602$79.18$839.5K21,759(D)

View →

Jun 26, 2026Jun 26 9:48 PMBaroldi Mariana
Proposed Sale
5,635$80.16$451.7K

View →

Jun 26, 2026Jun 26 9:47 PMO'NEIL PATRICK R.
Proposed Sale
3,069$80.00$245.5K

View →

Jun 26, 2026Jun 26 9:43 PMSchneider Eugene
Proposed Sale
47,884$81.05$3.9M

View →

Jun 25, 2026Jun 25 10:53 PMSwayze Eric
Proposed Sale
10,602$79.16$839.3K

View →

Jun 12, 2026Jun 16 9:26 PMHolly B. KordasiewiczEVP, Chief Development Officer
Sale
60,846$73.41$4.5M22,458(D)

View →

Jun 15, 2026Jun 16 9:26 PMBERTHELSEN SPENCER RDirector
Sale
8,000$73.49$587.9K156,013(D)

View →

Jun 15, 2026Jun 15 2:17 PMBERTHELSEN SPENCER R
Proposed Sale
8,000$73.49$587.9K

View →

Jun 12, 2026Jun 12 8:29 PMKordasiewicz Holly B.
Proposed Sale
60,846$73.41$4.5M

View →

Jun 1, 2026Jun 3 9:34 PMBERTHELSEN SPENCER RDirector
Sale
8,000$75.67$605.4K156,013(D)

View →

Jun 1, 2026Jun 1 2:47 PMBERTHELSEN SPENCER R
Proposed Sale
8,000$75.67$605.4K

View →

May 14, 2026May 15 10:15 PMBrett P MoniaDirector, Chief Executive Officer
Sale
3,220$78.68$253.3K242,662(D)

View →

May 13, 2026May 15 10:15 PMBrett P MoniaDirector, Chief Executive Officer
Sale
1,316$78.01$102.7K242,662(D)

View →

Page 1 of 10

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 2, 2026Jan 21 1:20 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
7,500$79.6716,600(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Option Exercise
11,11920,830(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
24,90045,730(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Option Exercise
7,01329,664(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Grant/Award
35,475$0.0037,725(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Option Exercise
28,72955,940(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Grant/Award
47,245$0.0068,825(D)

View →

Jan 15, 2026Jan 21 1:18 AMShannon L. DeversEVP, Chief Human Resources Ofc
Option Exercise
17,37743,029(D)

View →

Jan 15, 2026Jan 21 1:18 AMShannon L. DeversEVP, Chief Human Resources Ofc
Grant/Award
35,475$0.0052,704(D)

View →

Jan 15, 2026Jan 21 1:18 AMBrian BirchlerEVP, Corp and Development Ops
Option Exercise
20,08941,126(D)

View →

Jan 15, 2026Jan 21 1:18 AMBrian BirchlerEVP, Corp and Development Ops
Grant/Award
35,475$0.0050,801(D)

View →

Jan 15, 2026Jan 21 1:18 AMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
21,05517,434(D)

View →

Jan 15, 2026Jan 21 1:18 AMBENNETT C FRANKEVP, Chief Scientific Officer
Grant/Award
35,475$0.0027,109(D)

View →

Jan 15, 2026Jan 21 1:18 AMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
19,8875,474(I)

View →

Jan 15, 2026Jan 21 1:18 AMJoseph BaroldiEVP, Chief Business Officer
Grant/Award
39,375$0.009,374(I)

View →

← Previous

Page 3 of 3